CD34 and cancer: Importantly, progenies from both CD34+DNAM-1brightCXCR4+ and Lin-CD56-CD16+CD7- purified cells derived from cancer tissue, uninvolved tissue, and PBMC consistently expressed inhibiting NK cell receptors (KIRs and NKG2A) (Figures 6B, D).